ADAPTIVE BIOTECHNOLOGIES CORPORATION Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $15.37 million as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-11-05
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $15.37M.
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $96.80M.
- 2021-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $97.60M.
- 2021-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $103.80M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-09-30 | $15.37M 10-Q · filed 2025-11-05 |
| 2021-12-31 | $96.80M 10-K · filed 2022-02-15 |
| 2021-09-30 | $97.60M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $103.80M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $109.10M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $74.90M 10-K · filed 2021-02-24 |
| 2020-09-30 | $75.50M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $70.70M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $71.20M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $33.30M 10-K · filed 2020-02-26 |
| 2019-09-30 | $34.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $33.20M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |